News · 26 weeks50-33%
2025-12-072026-05-31
Mix3690d
- Insider17(47%)
- SEC Filings10(28%)
- Other5(14%)
- Earnings3(8%)
- Leadership1(3%)
Latest news
25 items- PR908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that on June 1, 2026, the Compensation Committee of its Board of Directors granted options to four new non-executive employees to purchase an aggregate of 179,912 shares of 908 Devices' common stock. The options were granted as a material inducement to employment with 908 Devices Inc. in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the 908 Devices Inc. 2026 Inducement Plan (the "Plan"). The inducement stock option has an exercise price of $8.63 per share, which is equal to the cl
- INSIDERLarge owner Awm Investment Company, Inc. sold $1,612,091 worth of 908 DEVICES (186,942 units at $8.62) (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERDirector Brown Christopher D. sold $270,000 worth of shares (30,000 units at $9.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 895,559 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERChief Financial Officer Griffith Joseph H. Iv sold $62,668 worth of shares (6,940 units at $9.03) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 132,956 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- SECSEC Form 144 filed by 908 Devices Inc.144 - 908 Devices Inc. (0001555279) (Subject)
- SECSEC Form SD filed by 908 Devices Inc.SD - 908 Devices Inc. (0001555279) (Filer)
- PR908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will present and host investor meetings at the 16th Annual East Coast IDEAS Conference on Wednesday, June 10, 2026. The Company presentation is scheduled to begin at 8:35 a.m. Eastern Time. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the company website at: www.908devices.com. About 908 Devices 908 Devices is
- SECAmendment: SEC Form SCHEDULE 13G/A filed by 908 Devices Inc.SCHEDULE 13G/A - 908 Devices Inc. (0001555279) (Subject)
- INSIDERLarge owner Awm Investment Company, Inc. sold $41,257 worth of shares (5,000 units at $8.25) (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSVP, Sales & Product Marketing Kenneweg John sold $148,048 worth of shares (18,255 units at $8.11), decreasing direct ownership by 24% to 57,784 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERLarge owner Awm Investment Company, Inc. sold $632,130 worth of 908 DEVICES (78,209 units at $8.08) (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERDirector Brown Christopher D. sold $144,600 worth of shares (20,000 units at $7.23) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 925,559 units (SEC Form 4)4 - 908 Devices Inc. (0001555279) (Issuer)
- SECSEC Form 10-Q filed by 908 Devices Inc.10-Q - 908 Devices Inc. (0001555279) (Filer)
- SEC908 Devices Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Regulation FD Disclosure8-K - 908 Devices Inc. (0001555279) (Filer)
- PR908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue OutlookRevenue increased 14% compared to prior year, growth in both Mass Spec and FTIR Acquired NIRLAB AG, expanding narcotics identification capabilities 908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2026. "We delivered a strong start to 2026, achieving 14% revenue growth and meaningful margin expansion," said Kevin J. Knopp, CEO and Co-founder. "We are also excited to announce the acquisition of NIRLAB AG, a strategic transaction that broadens our reach into the lower-cost, widely-deployable segm
- PR908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection PortfolioStrategic acquisition adds integrated hardware and cloud subscription platform powered by NIR spectroscopy 908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in Lausanne, Switzerland. The company delivers AI-powered, cloud-connected near-infrared (NIR) spectroscopy to perform handheld chemical analysis of narcotics in seconds. This acquisition expands 908 Devices' analytical portfolio and strengthens its leadership in narcotics detection with NIRLAB's solution for fast, high-volume screening for everyday law enforcement patrol. The NIRLAB handhel
- INSIDERSVP, Sales & Product Marketing Kenneweg John sold $53,185 worth of shares (7,787 units at $6.83) and converted options into 26,042 shares, increasing direct ownership by 32% to 76,039 units (SEC Form 4) (for withholding tax)4 - 908 Devices Inc. (0001555279) (Issuer)
- PR908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026908 Devices Inc. (NASDAQ:MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the first quarter 2026 before market open on Wednesday, May 6, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.908devices.com. The webcast will be archived and available for replay within 24 hours after the event. About 908 Devices 908 Devices is revolutionizing chemical analysis with its simple handheld dev
- INSIDERSEC Form 4 filed by SVP, Sales & Product Marketing Kenneweg John4 - 908 Devices Inc. (0001555279) (Issuer)
- SECSEC Form DEFA14A filed by 908 Devices Inc.DEFA14A - 908 Devices Inc. (0001555279) (Filer)
- SECSEC Form DEF 14A filed by 908 Devices Inc.DEF 14A - 908 Devices Inc. (0001555279) (Filer)
- INSIDERSEC Form 4 filed by Otitoju Kolawole A.4 - 908 Devices Inc. (0001555279) (Issuer)
- INSIDERSEC Form 3 filed by new insider Otitoju Kolawole A.3 - 908 Devices Inc. (0001555279) (Issuer)
- PR908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Mr. Otitoju brings over 25 years of proven executive leadership in strategy, business development, and P&L management across the medical technology, life sciences, and industrial sectors. Most recently, he served as Senior Vice President of
- INSIDERSEC Form 4 filed by Mccallion Kevin J.4 - 908 Devices Inc. (0001555279) (Issuer)
MASS FAQ
7 questionsWhat does 908 Devices Inc. do?
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time...Where does MASS stock trade?
908 Devices Inc. (MASS) is listed on NASDAQ.What sector and industry is MASS in?
908 Devices Inc. operates in the Industrials sector, Industrial Machinery/Components industry.When did 908 Devices Inc. go public?
908 Devices Inc. (MASS) completed its IPO in 2020.What are analysts saying about MASS?
908 Devices Inc. has had 5 recent analyst actions on file. The most recent action was from Leerink Partners: Outperform with a $1200.00 price target on 2025-08-05.What companies are similar to MASS?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), TMO (Thermo Fisher Scientific Inc), ETN (Eaton Corporation PLC), DE (Deere & Company). Compare MASS side-by-side with any of them on Quantisnow.How can I track MASS on Quantisnow?
Quantisnow aggregates 908 Devices Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MASS to receive live email and push alerts on every new disclosure.